Elias M M, Lunazzi G C, Passamonti S, Gazzin B, Miccio M, Stanta G, Sottocasa G L, Tiribelli C
Dipartimento Biochimica, Biofisica e Chimica delle Macromolecole, Università di Trieste, Italy.
Am J Physiol. 1990 Oct;259(4 Pt 2):F559-64. doi: 10.1152/ajprenal.1990.259.4.F559.
Bilirubin and phthalein dyes are taken up by the liver via a carrier-mediated mechanism operated at least in part by bilitranslocase (BTL). Because they also undergo renal transport, the presence and function of BTL was investigated in rat renal tubular plasma membrane vesicles. Transport of sulfobromophthalein (BSP) was enriched in basolateral domain of plasma membrane and followed the distribution pattern of Na(+)-K(+)-ATPase but not of gamma-glutamyltransferase. BSP uptake was inhibited by addition of monospecific antibodies raised against hepatic BTL. As in liver vesicles, BSP transport was electrogenic, being greatly accelerated by addition of valinomycin in presence of an inwardly directed K+ gradient. Apparent Km of BSP transport was 17 +/- 2 microM (n = 3 expts), one order of magnitude higher than that measured in liver; however, Vmax was similar to that described in liver vesicles (429 +/- 18 nmol BSP.mg protein-1.min-1, n = 3 expts). Competitive inhibition was observed with both unconjugated bilirubin (Ki, 2.9 +/- 0.2 microM) and rifamycin SV (Ki, 76 +/- 10 microM), known competitors for hepatic BTL-mediated transport of BSP. Immunoblotting studies with anti-BTL monospecific antibodies revealed presence of a single positive band only in basolateral-enriched membrane fraction; its apparent molecular mass was 37 kDa, virtually identical to that of hepatic protein. Immunohistochemistry confined presence of BTL to renal proximal tubules (RPT) We conclude that BTL is present in basolateral plasma membrane of RPT cells. Lower affinity of renal, compared with hepatic protein, for substrates might explain the marginal role of kidney in plasma clearance of bilirubin and cholephilic dyes.
胆红素和酞类染料通过一种至少部分由胆转运蛋白(BTL)介导的载体机制被肝脏摄取。由于它们也会经历肾脏转运,因此在大鼠肾小管质膜囊泡中研究了BTL的存在和功能。磺溴酞钠(BSP)的转运在质膜的基底外侧区域富集,并遵循钠钾ATP酶的分布模式,而不是γ-谷氨酰转移酶的分布模式。添加针对肝脏BTL产生的单特异性抗体可抑制BSP摄取。与肝囊泡一样,BSP转运是电生的,在存在内向钾离子梯度的情况下添加缬氨霉素可大大加速转运。BSP转运的表观Km为17±2微摩尔(n = 3次实验),比在肝脏中测得的值高一个数量级;然而,Vmax与肝囊泡中描述的值相似(429±18纳摩尔BSP·毫克蛋白-1·分钟-1,n = 3次实验)。未结合胆红素(Ki,2.9±0.2微摩尔)和利福霉素SV(Ki,76±10微摩尔)均观察到竞争性抑制,它们是肝脏BTL介导的BSP转运的已知竞争剂。用抗BTL单特异性抗体进行的免疫印迹研究显示,仅在基底外侧富集的膜部分存在一条单一的阳性条带;其表观分子量为37 kDa,与肝脏蛋白几乎相同。免疫组织化学将BTL的存在局限于肾近端小管(RPT)。我们得出结论,BTL存在于RPT细胞的基底外侧质膜中。与肝脏蛋白相比,肾脏蛋白对底物的亲和力较低,这可能解释了肾脏在胆红素和亲胆染料血浆清除中的边缘作用。